These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6105690)

  • 21. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract]   [Full Text] [Related]  

  • 22. Extrapyramidal side effects of antipsychotic medications.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
    Wilbur R; Kulik FA
    Prog Neuropsychopharmacol; 1980; 4(6):627-32. PubMed ID: 6111820
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia and antiparkinsonian medication.
    Chouinard G; De Montigny C; Annable L
    Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tardive dyskinesias].
    Mignot G
    Encephale; 1983; 9(2):151-66. PubMed ID: 6139271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia: review and update.
    Klawans HL; Goetz CG; Perlik S
    Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 32. [Main side effects of the use of neuroleptics].
    Morato GS; Takahashi RN
    AMB Rev Assoc Med Bras; 1982; 28(11-12):247-9. PubMed ID: 6133319
    [No Abstract]   [Full Text] [Related]  

  • 33. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors related to tardive dyskinesia.
    Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
    Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol in the treatment of neuroleptic-induced akathisia.
    Lipinski JF; Zubenko GS; Cohen BM; Barreira PJ
    Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
    Chaudhry R; Radonjic D; Waters B
    Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of low dose neuroleptics: a case control study of flupenthixol.
    Fritze J; Spreda I
    Eur Neuropsychopharmacol; 1997 Nov; 7(4):261-6. PubMed ID: 9443657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.